PainChek Limited (ASX: PCK) Webcast Replay
6th July, 2022
PainChek Limited (ASX: PCK) is a global healthcare tech company with a dominant 60% market share in Australia and an accelerating presence in the UK and New Zealand.
As a part of our ‘The Insiders: Meet the CEOs’ series, CEO Philip Daffas, provides valuable insights to the company, its key markets and industry, and future prospects.
Recorded on 6th July 2022 at 12pm (AEST).
Join the next The Insider: Meet the CEOs webcast
FEATURED SPEAKER
Philip Daffas
CEO - PainChek Limited (ASX: PCK)
PainChek is an Australian healthcare tech company and developer of the world’s first smart device-based pain assessment and monitoring application for infants and adults. The company’s SaaS AI platform is contracted to 126,000 patient beds across 1500 facilities globally, claiming a dominant 60% market share in Australia. In the year to March 2022, PainChek has shown consistent growth in customer revenue, contracted beds and subscriptions – demonstrated by its $3.2 million in ARR. The company is positioned to capture a near $1.3 billion global market opportunity spanning ANZ, Europe, the US, Canada, Japan and Singapore, leading up to FY24.
